Myths surrounding cancer can affect patient care and recovery. Dr Jayesh Sharma helps debunk four of them.

Pelareorep FDA Fast Track designation opens a registrational path for a viral immunotherapy targeting advanced anal cancer ...

First patient dosed in Phase 3 LUTEON[1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC).

A clinical trial finds that an algorithm routinely used to rule out pulmonary embolism works in patients with cancer, too — and could avoid up to 80,000 CT scans per year in the US.

Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby — ...

Wildfire PM2.5 differs from routine air pollution by composition, with higher elemental and organic carbon fractions that ...

Learn the single-leg stand in the Balance Exercise Package for patients with cancer to improve stability, strengthen balance ...

Nichols is a hematologist/oncologist, cancer researcher, and chief medical officer of Blood Cancer United. In May 2025, I joined more than 160 blood cancer advocates ...

Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors and may ...

Enough lip service. Enough ignoring the real pain of so many of your constituents. It’s just enough. Pass the Metastatic ...

Massive Bio, a global precision oncology company, today announced a partnership with FOMAT, the largest Embedded Research ...

The 340B program was created to help patients access medications at lower costs by allowing hospitals and clinics to purchase ...